AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2021
Sep 20, 2021
33298_dirs_2021-09-20_ea8bf555-f194-4ff9-a74f-a5bc5950b11a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-09-08
Reporting Person: BHATIA NAVEEN (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 0 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series B Convertible Preferred Stock | $3.25 | Common Stock (69034) | Indirect | ||
| Warrant | $4.60 | Common Stock (89744) | Indirect |
Footnotes
F1: The preferred stock is perpetual and therefore has no expiration date.
F2: The warrant expires on November 3, 2025.
F3: The Reporting Person holds a 6.37% interest in PA001 Holdings, LLC.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17